Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

20.58USD
14 Nov 2018
Change (% chg)

$-1.05 (-4.85%)
Prev Close
$21.63
Open
$22.01
Day's High
$22.01
Day's Low
$20.04
Volume
90,614
Avg. Vol
63,418
52-wk High
$45.61
52-wk Low
$15.37

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -1.08 -- --
ROI: -- -0.29 14.22
ROE: -- 0.40 15.99

Earnings vs. Estimates